Sanofi to invest €80m in biopharmaceutical firm BioNTech
French multinational pharmaceutical company Sanofi investing €80m in equity in BioNTech, which is claimed to be the Europe’s largest privately-held biopharmaceutical firm focused on the development of individualized therapies for cancer and the prevention of infectious diseases.